Biogen Inc. (BIIB) was upgraded to a "buy" by TheStreet's Quant Ratings service on Wednesday. This biotech name has made a chart that could be challenging to many traders and investors. Let's drill down and see if an easier approach to the long side can be found.
More from Stocks
Let's check out the charts and see if the hoarding phase is over.
If you're asking how much longer the market can ignore all the negative events that are so glaringly obvious, then you're not alone.
With price pushing above resistance today, a small upside play could be considered here, especially if you remain under invested.